Impact News +++ Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call... (Business Wire) +++ SENSUS HEALTHCARE Aktie +3,91%

EVOLENT HEALTH Aktie

>EVOLENT HEALTH Aktienkurs

7.95 EUR (Tradegate)

Ask: 8 EUR / 1870 Stück

Bid: 7.9 EUR / 1910 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>EVOLENT HEALTH Performance

1 Woche: -18,5%

1 Monat: -12,6%

3 Monate: -0,3%

6 Monate: -17,4%

1 Jahr: -59,5%

laufendes Jahr: -25,4%

>EVOLENT HEALTH Aktie

Name:

EVOLENT HEALTH A DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US30050B1017 / A14UCN

Symbol/ Ticker:

9EH (Frankfurt) / EVH (NYSE)

Kürzel:

FRA:9EH, ETR:9EH, 9EH:GR, NYSE:EVH

Index:

Webseite:

https://www.evolenthealth..

Marktkapitalisierung:

974.11 Mio. EUR

Umsatz:

2037.18 Mio. EUR

EBITDA:

97.48 Mio. EUR

Gewinn je Aktie:

-1.04 EUR

Schulden:

903.05 Mio. EUR

Liquide Mittel:

223.18 Mio. EUR

Umsatz-/ Gewinnwachstum:

9.95% / 1.51%

KGV/ KGV lG:

- / 27.33

KUV/ KBV/ PEG:

0.47 / 1.11 / -

Gewinnm./ Eigenkapitalr.:

-4.54% / -10.99%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

EVOLENT HEALTH

Letzte Datenerhebung:

24.07.25

>Eigentümer

Aktien: 117.4 Mio. St.

f.h. Aktien: 103.47 Mio. St.

Insider Eigner: 1.41%

Instit. Eigner: 109.46%

Leerverk. Aktien: 14.34%

>Peer Group

ABEONA THERAPEUTICS

AKEBIA

ALDEYRA

ANAPTYSBIO

ANNOVIS BIO

BIO-RAD A

BIO-TECHNE

CLEARSIDE BIOMEDICAL

INTEGRA LIFESCIENCES

PACIFIC BIOSCIENCES

>EVOLENT HEALTH Chart & Kurs - NYSE

>EVOLENT HEALTH News

18.07.25 - 01:12	The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts (Benzinga)
	Latest Ratings for EVH DateFirmActionFromTo Nov 2021JP MorganUpgradesNeutralOverweight Aug 2021Canaccord GenuityMaintainsBuy Mar 2021Canaccord GenuityMaintainsBuy View More Analyst Ratings for EVH View the Latest Analyst Ratings read more...

14.07.25 - 14:02	Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 (PR Newswire)
	Company to Participate in Upcoming Conferences WASHINGTON, July 14, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2025 financial results on......

09.07.25 - 14:27	Evolent Health taps David Lim as chief clinical officer (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.06.25 - 16:00	Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar? (Zacks)
	Evolent Health (EVH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term....

20.06.25 - 12:33	Evolent reiterates Q2 and full year guidance for Adjusted EBITDA (PR Newswire)
	Notes accelerating 2026 revenue bookings forecast Secures incremental non-dilutive financing WASHINGTON, June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that based on......

10.05.25 - 01:00	Expert Outlook: Evolent Health Through The Eyes Of 9 Analysts (Benzinga)
	Latest Ratings for EVH DateFirmActionFromTo Nov 2021JP MorganUpgradesNeutralOverweight Aug 2021Canaccord GenuityMaintainsBuy Mar 2021Canaccord GenuityMaintainsBuy View More Analyst Ratings for EVH View the Latest Analyst Ratings read more...

09.05.25 - 21:15	Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
	Although the revenue and EPS for Evolent Health (EVH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

09.05.25 - 02:30	Evolent Health (EVH) Q1 Earnings Lag Estimates (Zacks)
	Evolent Health (EVH) delivered earnings and revenue surprises of -33.33% and 4.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...

08.05.25 - 22:48	Evolent Health Non-GAAP EPS of $0.06 misses by $0.04, revenue of $483.6M beats by $23.32M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

08.05.25 - 22:12	Evolent Announces First Quarter 2025 Results (PR Newswire)
	WASHINGTON, May 8, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced......

07.05.25 - 17:15	Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here′s is How to Trade (Zacks)
	The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock....

22.04.25 - 12:30	Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors (PR Newswire)
	Former CFO of CVS Health, Aetna and Coventry Health Care brings deep experience driving growth and profitability. Mr. Guertin's nomination represents continuation of Evolent's board refreshment efforts. WASHINGTON, April 22, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH)......

10.04.25 - 23:01	Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 (PR Newswire)
	Company to Participate in Upcoming Conferences WASHINGTON, April 10, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2025 financial results on......

10.03.25 - 15:02	Insiderhandel: Aufsichtsrat kauft Aktien von Evolent Health im Wert von 50058 USD (Insiderkauf)
	Glass, Russell Monroe - Aufsichtsrat - Tag der Transaktion: 2025-03-06...

10.03.25 - 15:02	Insiderhandel: Aufsichtsrat kauft Aktien von Evolent Health im Wert von 273750 USD (Insiderkauf)
	Jelinek, Richard M. - Aufsichtsrat - Tag der Transaktion: 2025-03-07...

10.03.25 - 15:02	Insiderhandel: Aufsichtsrat kauft Aktien von Evolent Health im Wert von 99498 USD (Insiderkauf)
	Keck, Kim - Aufsichtsrat - Tag der Transaktion: 2025-03-07...

10.03.25 - 15:02	Insiderhandel: Chief Executive Officer kauft Aktien von Evolent Health im Wert von 497577 USD (Insiderkauf)
	Blackley, Seth - Vorstand - Tag der Transaktion: 2025-03-06...

10.03.25 - 15:02	Insiderhandel: Aufsichtsrat kauft Aktien von Evolent Health im Wert von 17620 USD (Insiderkauf)
	Barbarosh, Craig A. - Aufsichtsrat - Tag der Transaktion: 2025-03-06...

10.03.25 - 15:02	Insiderhandel: Aufsichtsrat kauft Aktien von Evolent Health im Wert von 25518 USD (Insiderkauf)
	Holder, Diane - Aufsichtsrat - Tag der Transaktion: 2025-03-06...

10.03.25 - 15:02	Insiderhandel: Aufsichtsrat kauft Aktien von Evolent Health im Wert von 139050 USD (Insiderkauf)
	Springstubb, Brendan B. - Aufsichtsrat - Tag der Transaktion: 2025-03-07...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Im strengen Sinne des Wortes hat es nie eine wirkliche Demokratie gegeben und wird es niemals geben. - Jean-Jacques Rousseau

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram